Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteers
Status:
Completed
Trial end date:
2014-01-09
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine the bioequivalence of 5 x 0.1 milligram (mg) capsules
compared to 1 x 0.5 mg capsule of dutasteride in healthy male subjects. The results of this
study are expected to support registration applications for androgenetic alopecia (AGA) in
Japan and other international markets.